CNS Neuroscience & Therapeutics: review time and acceptance speed
ISSN 1755-5930 · ISSN 1755-5949 · Wiley · Neuroscience
Half of the articles CNS Neuroscience & Therapeutics accepted in 2025 were accepted within 133 days of submission (n = 485); the middle half took 95–191 days.
Accepted articles only · dates deposited by the publisher in PubMed · data as of Sep 15, 2026
How long does CNS Neuroscience & Therapeutics take to accept a paper?
| Year | Articles (n) | 25th pct | Median | 75th pct | 90th pct | Accepted <14 days | Have a revised date |
|---|---|---|---|---|---|---|---|
| 2025 | 485 | 95 | 133 | 191 | 268 | 0.0% | 100% |
| 2024 | 474 | 85 | 126 | 182 | 228 | 0.2% | 99% |
| 2023 | 468 | 80 | 112 | 171 | 261 | 0.0% | 99% |
| 2022 | 236 | 81 | 113 | 160 | 231 | 0.0% | 100% |
| 2021 | 142 | 78 | 104 | 131 | — | 0.0% | 99% |
| 2020 | 105 | 50 | 79 | 106 | — | 2.9% | 99% |
- 2026: not shown yet — a year is reported once late-indexed articles have arrived (at least 180 days after it ends).
Research articles vs reviews (2025)
| Type | n | 25th pct | Median | 75th pct |
|---|---|---|---|---|
| Research articles | 426 | 97 | 135 | 195 |
| Reviews | 58 | 81 | 115 | 167 |
Distribution in 2025
Show as a table
| Days | Articles | Share |
|---|---|---|
| 0–29 | 2 | 0.4% |
| 30–59 | 34 | 7.0% |
| 60–89 | 66 | 13.6% |
| 90–119 | 93 | 19.2% |
| 120–149 | 91 | 18.8% |
| 150–179 | 60 | 12.4% |
| 180–209 | 45 | 9.3% |
| 210–239 | 26 | 5.4% |
| 240–269 | 20 | 4.1% |
| 270–299 | 14 | 2.9% |
| 300–329 | 6 | 1.2% |
| 330–359 | 10 | 2.1% |
| 360+ | 18 | 3.7% |
From acceptance to online publication
Not enough articles with both an acceptance date and an online publication date to measure the time to online publication.
Read these numbers carefully
- These times describe articles the journal accepted. Rejected manuscripts never appear in public data, so they cannot tell you how long a rejection takes.
- Dates are the ones the publisher deposited with PubMed. Some publishers record the date a revised manuscript arrived as the submission date, which makes review look faster.
- Invited articles and special issues can move faster than regular submissions.
Open access status and publishing fees
Open access (listed in DOAJ). Listed APC: $4,550 (DOAJ).
No institutional payments for this journal are recorded in OpenAPC.
Many journals waive or reduce fees for authors from eligible countries or institutions with publishing agreements — check with the journal and your library.
Integrity and indexing signals
Facts from public records, shown without judgement. See the methodology for why each can be worth a closer look.
| Listed in DOAJ | Yes (DOAJ record) |
|---|---|
| Articles indexed for MEDLINE in 2025 | Yes |
| Retractions | 2 retracted articles among 1,802 added to PubMed in 2021–2025 (1.11 per 1,000), per the Retraction Watch Database. |
| Accepted within 14 days of submission | 0.0% of 2025 articles |
| Publication volume | 494 articles added to PubMed in 2025 (+0% vs 2024). |
Topics and scope
- Neuroinflammation and Neurodegeneration Mechanisms (11% of indexed topics)
- Neuroscience and Neuropharmacology Research (6% of indexed topics)
- Functional Brain Connectivity Studies (6% of indexed topics)
- Alzheimer's disease research and treatments (6% of indexed topics)
- Parkinson's Disease Mechanisms and Treatments (6% of indexed topics)
- Neurological disorders and treatments (5% of indexed topics)
Similar journals — faster or cheaper, side by side
Journals publishing on the most similar topics (OpenAlex), ordered by similarity. Only 2025 figures are compared with the 2025 median of CNS Neuroscience & Therapeutics, 133 days.
| Paid APC median | DOAJ | MEDLINE | |||
|---|---|---|---|---|---|
| Molecular Neurobiology | 156 (2025, n = 936) | ≈$4,590 | — | No | Yes |
| Neurotherapeutics | 90 (2025, n = 209) | $3,900 | — | Yes | Yes |
| Journal of Neuroinflammation | 93 (2025, n = 348) | $4,390 | $3,184 (22 payments) | Yes | Yes |
| Frontiers in Aging Neuroscience | 98 (2025, n = 704) | ≈$3,850 | $3,263 (52 payments) | Yes | No |
| Neuroscience Bulletin | 111 (2025, n = 186) | ≈$4,490 | — | No | Yes |
| NeuroMolecular Medicine | 64 (2025, n = 74) | ≈$4,990 | — | No | Yes |
| Neural Regeneration Research | 122 (2025, n = 518) | $2,500 | — | Yes | No |
| Glia | 173 (2025, n = 130) | ≈$5,450 | — | No | Yes |
No journals match these filters.
Frequently asked questions
How long does CNS Neuroscience & Therapeutics take to accept a paper?
Half of the articles CNS Neuroscience & Therapeutics accepted in 2025 were accepted within 133 days of submission (n = 485); the middle half took 95–191 days. Based on dates in PubMed for accepted articles only.
Does CNS Neuroscience & Therapeutics charge an article processing charge (APC)?
Listed APC: $4,550 (DOAJ).
Sources and method
Journal identity: ISSN-L 1755-5930; NLM ID 101473265; OpenAlex record. Speed figures use 485 articles accepted in 2025 with valid dates; excluded records for that year: none.
Spotted a problem with this journal's data, or are you the publisher? Report a correction or email rafiq@gradsummit.com. Verified errors are corrected within five business days.
Get the free Journal Submission Go/No-Go Checklist
The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.
Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.